US Stock MarketDetailed Quotes
ATRA Atara Biotherapeutics
- 11.310
- +1.210+11.98%
Close Nov 8 16:00 ET
- 11.580
- +0.270+2.39%
Post 20:01 ET
64.17MMarket Cap-290P/E (TTM)
11.480High10.020Low154.43KVolume10.100Open10.100Pre Close1.68MTurnover3.29%Turnover RatioLossP/E (Static)5.67MShares39.50052wk High-0.58P/B53.12MFloat Cap4.96552wk Low--Dividend TTM4.70MShs Float1638.998Historical High--Div YieldTTM14.46%Amplitude4.965Historical Low10.872Avg Price1Lot Size
About Atara Biotherapeutics Company
Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.
Company Profile
SymbolATRA
Company NameAtara Biotherapeutics
Listing DateOct 16, 2014
Issue Price11.00
Founded2012
CEODr. AnhCo Nguyen, PhD
MarketNASDAQ
Employees225
Fiscal Year Ends12-31
Address2380 Conejo Spectrum Street,Suite 200
CityThousand Oaks
ProvinceCalifornia
CountryUnited States of America
Zip Code91320
Phone1-805-623-4211
Websitehttp://www.atarabio.com
Company Executives
-
Name
- Position
- Salary
-
Amar Murugan
- Executive Vice President and Chief Legal Officer
- 2.31M
-
Dr. AnhCo Nguyen, PhD
- President, Chief Financial Officer and Director
- 2.28M
-
Eric Hyllengren
- Executive Vice President, Chief Financial Officer, Chief Operating Officer and Principal Accounting Officer
- --
-
Jill Henrich
- Executive Vice President, Global Head Regulatory Affairs and Quality
- --
-
Dr. Pascal Touchon, D.V.M.
- Chairman of the Board
- 4.38M
-
Dr. Carol G. Gallagher,Pharm.D.
- Lead Independent Director
- 260.23K
-
Matthew K. Fust
- Independent Director
- 239.73K
-
Ameet Mallik
- Independent Director
- 219.52K
-
William K. Heiden
- Independent Director
- 237.23K
-
Dr. Maria Grazia Roncarolo, M.D.
- Independent Director
- 229.73K
-
Gregory A. Ciongoli
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
